Amalio Telenti
Stable virulence levels in the HIV epidemic of Switzerland over two decades
Müller V, Bonhoeffer S, Günthard H, Vernazza P, Bernasconi E, Telenti A, Furrer H, Klimkait T, Perrin L, Ledergerber B, Swiss HIV Cohort Study. Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS (London, England) 2006; 20:889-94.
04.04.2006Stable virulence levels in the HIV epidemic of Switzerland over two decades
04.04.2006AIDS (London, England) 2006; 20:889-94
Müller Viktor, Bonhoeffer Sebastian, Günthard Huldrych F, Vernazza Pietro, Bernasconi Enos, Telenti Amalio, Furrer Hansjakob, Klimkait Thomas, Perrin Luc, Ledergerber Bruno, Swiss HIV Cohort Study
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia
Rotger M, Telenti A, Rickenbach M, Bernasconi E, Drechsler H, Vernazza P, Furrer H, Günthard H, Bleiber G, Taffé P, Swiss HIV Cohort Study. Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. The Journal of infectious diseases 2005; 192:1381-6.
15.10.2005Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia
15.10.2005The Journal of infectious diseases 2005; 192:1381-6
Rotger Margalida, Telenti Amalio, Rickenbach Martin, Bernasconi Enos, Drechsler Henning, Vernazza Pietro, Furrer Hansjakob, Günthard Huldrych F, Bleiber Gabriela, Taffé Patrick, Swiss HIV Cohort Study
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders
Tarr P, Telenti A, Ledergerber B, Rickenbach M, Darioli R, Bernasconi E, Vernazza P, Weber R, Battegay M, Hirschel B, Martinez R, Rotger M, Furrer H, Bleiber G, Taffé P, Swiss HIV Cohort Study. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. The Journal of infectious diseases 2005; 191:1419-26.
01.05.2005Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders
01.05.2005The Journal of infectious diseases 2005; 191:1419-26
Tarr Philip E, Telenti Amalio, Ledergerber Bruno, Rickenbach Martin, Darioli Roger, Bernasconi Enos, Vernazza Pietro, Weber Rainer, Battegay Manuel, Hirschel Bernard, Martinez Raquel, Rotger Margalida, Furrer Hansjakob, Bleiber Gabriela, Taffé Patrick, Swiss HIV Cohort Study
Infrequent transmission of HIV-1 drug-resistant variants
Yerly S, Perrin L, Hirschel B, Perneger T, Bernard M, Gebhardt M, Rickenbach M, Bürgisser P, Chanzy B, Furrer H, Battegay M, Vernazza P, Chave J, Kaiser L, Flepp M, Telenti A, Jost S, Swiss HIV Cohort Study. Infrequent transmission of HIV-1 drug-resistant variants. Antiviral therapy 2004; 9:375-84.
01.06.2004Infrequent transmission of HIV-1 drug-resistant variants
01.06.2004Antiviral therapy 2004; 9:375-84
Yerly Sabine, Perrin Luc, Hirschel Bernard, Perneger Thomas, Bernard Marie-Charlotte, Gebhardt Martin, Rickenbach Martin, Bürgisser Philippe, Chanzy Bruno, Furrer Hansjakob, Battegay Manuel, Vernazza Pietro, Chave Jean-Philippe, Kaiser Laurent, Flepp Markus, Telenti Amalio, Jost Stéphanie, Swiss HIV Cohort Study
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
Young J, Bucher H, Battegay M, Vernazza P, Telenti A, Hirschel B, Bernasconi E, Furrer H, Rickenbach M, Flepp M, Spirig R, De Geest S, Swiss HIV Cohort Study Group. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. BMJ (Clinical research ed.) 2004; 328:15.
03.01.2004Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
03.01.2004BMJ (Clinical research ed.) 2004; 328:15
Young Jim, Bucher Heiner C, Battegay Manuel, Vernazza Pietro, Telenti Amalio, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Flepp Markus, Spirig Rebecca, De Geest Sabina, Swiss HIV Cohort Study Group
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
Kaufmann G, Battegay M, Egger M, Rickenbach M, Bernasconi E, Vernazza P, Ledergerber B, Hirschel B, Telenti A, Furrer H, Opravil M, Pantaleo G, Perrin L, Swiss HIV Cohort Study Group. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Archives of internal medicine 2003; 163:2187-95.
13.10.2003CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
13.10.2003Archives of internal medicine 2003; 163:2187-95
Kaufmann Gilbert R, Battegay Manuel, Egger Matthias, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Ledergerber Bruno, Hirschel Bernard, Telenti Amalio, Furrer Hansjakob, Opravil Milos, Pantaleo Guiseppe, Perrin Luc, Swiss HIV Cohort Study Group
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
Jaggy C, Hirschel B, Bernasconi E, Vernazza P, Flepp M, Battegay M, Telenti A, Furrer H, Rickenbach M, Egger M, Schwarz C, Ledergerber B, von Overbeck J, Swiss HIV Cohort Study. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet 2003; 362:877-8.
13.09.2003Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
13.09.2003Lancet 2003; 362:877-8
Jaggy Christian, Hirschel Bernard, Bernasconi Enos, Vernazza Pietro, Flepp Markus, Battegay Manuel, Telenti Amalio, Furrer Hans-Jakob, Rickenbach Martin, Egger Matthias, Schwarz Claude, Ledergerber Bruno, von Overbeck Jan, Swiss HIV Cohort Study
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study
Wolf K, Bucher H, Weber R, Telenti A, Hirschel B, Bernasconi E, Furrer H, Flepp M, Vernazza P, Rickenbach M, Young J, Swiss HIV Cohort Study. Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2003; 33:494-9.
01.08.2003Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study
01.08.2003Journal of acquired immune deficiency syndromes (1999) 2003; 33:494-9
Wolf Katja, Bucher Heiner C, Weber Rainer, Telenti Amalio, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Flepp Markus, Vernazza Pietro, Rickenbach Martin, Young James, Swiss HIV Cohort Study
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART
Fagard C, Hirschel B, Perrin L, Perneger T, Oxenius A, Ebnöther C, Telenti A, Bernasconi E, Vernazza P, Egger M, Hirsch H, Günthard H, Le Braz M, Swiss HIV Cohort Study. A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART. AIDS (London, England) 2003; 17:1487-92.
04.07.2003A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART
04.07.2003AIDS (London, England) 2003; 17:1487-92
Fagard Catherine, Hirschel Bernard, Perrin Luc, Perneger Thomas, Oxenius Annette, Ebnöther Corinna, Telenti Amalio, Bernasconi Enos, Vernazza Pietro, Egger Martin, Hirsch Hans H, Günthard Huldrych, Le Braz Michelle, Swiss HIV Cohort Study
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection
Fagard C, Price D, Dawson S, Klimkait T, Perneger T, McLean A, Clotet B, Gatell J, Perrin L, Plana M, Phillips R, Hirschel B, Yerly S, Leduc D, Oxenius A, Günthard H, Garcia F, Le Braz M, Mestre G, Battegay M, Furrer H, Vernazza P, Bernasconi E, Telenti A, Weber R, Swiss HIV Cohort Study. A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. Archives of internal medicine 2003; 163:1220-6.
26.05.2003A prospective trial of structured treatment interruptions in human immunodeficiency virus infection
26.05.2003Archives of internal medicine 2003; 163:1220-6
Fagard Catherine, Price David, Dawson Sara J, Klimkait Thomas, Perneger Thomas V, McLean Angela, Clotet Bonaventura, Gatell Jose M, Perrin Luc, Plana Montserrat, Phillips Rodney, Hirschel Bernard, Yerly Sabine, Leduc Dominique, Oxenius Annette, Günthard Huldrych, Garcia Felipe, Le Braz Michelle, Mestre Gabriel, Battegay Manuel, Furrer Hansjakob, Vernazza Pietro, Bernasconi Enos, Telenti Amalio, Weber Rainer, Swiss HIV Cohort Study
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
Greub G, Telenti A, Phillips A, Hirschel B, Günthard H, Bernasconi E, Vernazza P, Battegay M, Furrer H, Francioli P, Miller V, Perrin L, Staszewski S, Ledergerber B, Cozzi-Lepri A, Frankfurt HIV Clinic Cohort and the Swiss HIV Cohort Study. Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy. AIDS (London, England) 2002; 16:1967-9.
27.09.2002Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
27.09.2002AIDS (London, England) 2002; 16:1967-9
Greub Gilbert, Telenti Amalio, Phillips Andrew N, Hirschel Bernard, Günthard Huldrych F, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Furrer Hansjakob, Francioli Patrick, Miller Veronica, Perrin Luc, Staszewski Schlomo, Ledergerber Bruno, Cozzi-Lepri Alessandro, Frankfurt HIV Clinic Cohort and the Swiss HIV Cohort Study
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study
Bernasconi E, Telenti A, Rickenbach M, Weber R, Opravil M, Chave J, Boggian K, Hirschel B, Haensel A, Furrer H, Flepp M, Junghans C, Boubaker K, Swiss HIV Cohort Study. Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2002; 31:50-5.
01.09.2002Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study
01.09.2002J Acquir Immune Defic Syndr 2002; 31:50-5
Bernasconi Enos, Telenti Amalio, Rickenbach Martin, Weber Rainer, Opravil Milos, Chave Jean-Philippe, Boggian Katia, Hirschel Bernard, Haensel Alexander, Furrer Hans-Jakob, Flepp Markus, Junghans Cornelia, Boubaker Karim, Swiss HIV Cohort Study
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
Fellay J, Telenti A, Eap C, Vernazza P, Schinkel A, Ruiz L, Retelska D, Pantaleo G, Opravil M, Furrer H, Decosterd L, Chave J, Buclin T, Back D, Meaden E, Marzolini C, Swiss HIV Cohort Study. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002; 359:30-6.
05.01.2002Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
05.01.2002Lancet 2002; 359:30-6
Fellay Jacques, Telenti Amalio, Eap Chin B, Vernazza Pietro, Schinkel Alfred H, Ruiz Lidia, Retelska Dorota, Pantaleo Giuseppe, Opravil Milos, Furrer Hansjakob, Decosterd Laurent A, Chave Jean Philippe, Buclin Thierry, Back David J, Meaden Emma R, Marzolini Catia, Swiss HIV Cohort Study